Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

The 2026 Income Stronghold: Reasons Big Pharma is the Safe Investment for the Upcoming Year

30 Dec, 2025

5 Major Pharmaceutical Stocks Likely to Excel in 2026 - TradingView

23 Dec, 2025

ABBV or AZN: Which Pharmaceutical Stock Represents a Superior Investment Opportunity at This Time? - TradingView

23 Dec, 2025

FDA Assesses Priority Review Vouchers for Merck Medications Amidst Novo Nordisk and Takeda Developments...

18 Dec, 2025

See More